Kosary C L
Div. of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD 20892.
Semin Surg Oncol. 1994 Jan-Feb;10(1):31-46. doi: 10.1002/ssu.2980100107.
The prognostic impact of FIGO stage, histology, histologic grade, age and race in survival for cancers of the female gynecological (cervix, endometrium, ovary, vulva, vagina) were examined using cases obtained from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program that were diagnosed between 1973 and 1987. Utilizing Cox proportional hazards modeling and relative survival rates analysis of 17,119 cases of cervical cancer indicated that the International Federation of Gynecology and Obstetrics (FIGO) stage, histology, histological grade, lymph node status, and age at diagnosis were all independently prognostic. No evidence was found of survival differences between squamous cell carcinoma and adenocarcinoma. Younger women were not found to have a poorer prognosis, survival declined with increased age. Analysis of 41,120 cases of endometrial cancer indicated that FIGO stage, histology, histologic grade, lymph node status, age at diagnostic, and race were all prognostic factors. Clear cell adenocarcinoma, leiomyosarcoma, and mixed mullerian tumors were all found to have poorer prognosis. Analysis of 21,240 cases of ovarian cancer indicated that FIGO stage, histology, histologic grade, lymph node status, age at diagnosis, presence of ascites, and race were all prognostically significant. Analysis of 2,575 cases of vulvar cancer indicated that FIGO stage, histology, histologic grade, age, and race were all prognostically significant. Analysis of 916 cases of vaginal cancer indicated that FIGO stage, histologic grade, lymph node status, and age are all prognostically significant. Additional analysis of the data by combinations of independent prognostic factors indicates that the interaction of factors may be more predictive of outcome than any one factor separately.
利用从美国国立癌症研究所的监测、流行病学和最终结果(SEER)计划中获取的1973年至1987年期间确诊的病例,研究了国际妇产科联盟(FIGO)分期、组织学、组织学分级、年龄和种族对女性妇科癌症(子宫颈癌、子宫内膜癌、卵巢癌、外阴癌、阴道癌)生存率的预后影响。对17119例子宫颈癌病例进行Cox比例风险建模和相对生存率分析表明,FIGO分期、组织学、组织学分级、淋巴结状态和诊断时的年龄均具有独立的预后意义。未发现鳞状细胞癌和腺癌之间存在生存差异。未发现年轻女性预后较差,生存率随年龄增长而下降。对41120例子宫内膜癌病例的分析表明,FIGO分期、组织学、组织学分级、淋巴结状态、诊断时的年龄和种族均为预后因素。透明细胞腺癌、平滑肌肉瘤和混合性苗勒管肿瘤的预后均较差。对21240例卵巢癌病例的分析表明,FIGO分期、组织学、组织学分级、淋巴结状态、诊断时的年龄、腹水的存在和种族均具有预后意义。对2575例外阴癌病例的分析表明,FIGO分期、组织学、组织学分级、年龄和种族均具有预后意义。对916例阴道癌病例的分析表明,FIGO分期、组织学分级、淋巴结状态和年龄均具有预后意义。通过独立预后因素组合对数据进行的进一步分析表明,因素之间的相互作用可能比任何一个单独因素更能预测结果。